Skip to main content

Table 3 Correlation of HR-/HER2- subgroups with pCR (univariate logistic regression analysis)

From: Identification of biology-based breast cancer types with distinct predictive and prognostic features: role of steroid hormone and HER2 receptor expression in patients treated with neoadjuvant anthracycline/taxane-based chemotherapy

 

n

events

% pCR

OR

95% CI

p

HR-/HER2- subgroups

Ki67 (per 10%)

29

7

-

1.92

1.21-3.04

0.006

CK5/6

30

8

    

   negative

24

5

20.8

1.00

  

   positive

6

3

50.0

3.80

0.58-24.88

0.127

COX-2

26

7

    

   negative

9

3

33.3

1.00

  

   positive

17

4

23.5

0.62

0.10-3.66

0.593

YB-1

30

7

    

   negative

22

5

22.7

1.00

  

   positive

8

2

25.0

1.13

0.17-7.47

0.896

  1. OR: odds ratio; CI: confidence interval.